Investor mix
3 investors on record; lead investors include BridgeBio; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 1 | 33% |
| Other / undisclosed | 2 | 67% |
Biotechnology company pioneering precision medicine for rare dermatological conditions
3 investors on record; lead investors include BridgeBio; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Private equity | 1 | 33% |
| Other / undisclosed | 2 | 67% |